We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
(+7.2%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$408M |
| 2 |
NVIDIA
NVDA
|
+$395M |
| 3 |
Microsoft
MSFT
|
+$382M |
| 4 |
Amazon
AMZN
|
+$253M |
| 5 |
Palantir
PLTR
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$285M |
| 2 |
NextEra Energy
NEE
|
+$207M |
| 3 |
West Pharmaceutical
WST
|
+$168M |
| 4 |
Broadcom
AVGO
|
+$133M |
| 5 |
Meta Platforms (Facebook)
META
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.42% |
| 2 | Consumer Discretionary | 10.78% |
| 3 | Consumer Staples | 10.15% |
| 4 | Industrials | 10.05% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
2076
DELISTED
Sage Therapeutics
SAGE
| $99.3K | ﹤0.01% |
18,281
+4,350
| +31% | +$26.6K |
|
|
YMAB
2077
DELISTED
Y-mAbs Therapeutics
YMAB
| $99K | ﹤0.01% |
+12,645
| New | +$154K |
|
2078
Bit Digital
BTBT
$484M
| $98.9K | ﹤0.01% |
33,753
+11,107
| +49% | +$43.7K |
|
2079
SIGA Technologies
SIGA
$223M
| $98.7K | ﹤0.01% |
16,424
+3,455
| +27% | +$23.1K |
|
2080
Allogene Therapeutics
ALLO
$601M
| $98.2K | ﹤0.01% |
46,082
+9,388
| +26% | +$23.2K |
|
2081
Nu Skin
NUS
$247M
| $96.3K | ﹤0.01% |
+13,970
| New | +$96.1K |
|
2082
8x8 Inc
EGHT
$247M
| $96.1K | ﹤0.01% |
36,000
+11,846
| +49% | +$30.4K |
|
2083
Granite Ridge Resources
GRNT
$640M
| $95.8K | ﹤0.01% |
+14,828
| New | +$91.8K |
|
2084
CryoPort
CYRX
$775M
| $95.3K | ﹤0.01% |
+12,250
| New | +$91.3K |
|
2085
Pagaya Technologies
PGY
$1.32B
| $94.2K | ﹤0.01% |
+10,140
| New | +$107K |
|
2086
SmartRent
SMRT
$183M
| $94.2K | ﹤0.01% |
53,820
+17,710
| +49% | +$29.7K |
|
|
CTV
2087
DELISTED
Innovid Corp.
CTV
| $94.1K | ﹤0.01% |
30,450
+10,321
| +51% | +$24.4K |
|
|
HOUS
2088
DELISTED
Anywhere Real Estate
HOUS
| $91.2K | ﹤0.01% |
27,640
+9,095
| +49% | +$39K |
|
2089
4D Molecular Therapeutics
FDMT
$526M
| $91.2K | ﹤0.01% |
16,369
+3,783
| +30% | +$29.7K |
|
2090
Cerence
CRNC
$382M
| $91K | ﹤0.01% |
+11,586
| New | +$58.2K |
|
2091
Vanda Pharmaceuticals
VNDA
$312M
| $90.1K | ﹤0.01% |
18,815
+4,599
| +32% | +$22.1K |
|
|
TRUE
2092
DELISTED
TrueCar
TRUE
| $90K | ﹤0.01% |
24,123
+7,938
| +49% | +$31.2K |
|
2093
Aquestive Therapeutics
AQST
$462M
| $89.8K | ﹤0.01% |
25,232
+11,200
| +80% | +$51.6K |
|
|
BRY
2094
DELISTED
Berry Corp
BRY
| $89.1K | ﹤0.01% |
21,574
+7,100
| +49% | +$32.8K |
|
2095
Corsair Gaming
CRSR
$1.05B
| $89.1K | ﹤0.01% |
+13,476
| New | +$93.5K |
|
|
ACRE
2096
Ares Commercial Real Estate
ACRE
$252M
| $88.6K | ﹤0.01% |
15,045
+4,950
| +49% | +$33.3K |
|
2097
Voyager Therapeutics
VYGR
$187M
| $88.1K | ﹤0.01% |
15,543
-8,311
| -35% | -$53.6K |
|
2098
Advantage Solutions
ADV
$484M
| $87.1K | ﹤0.01% |
1,193
+384
| +47% | +$31.4K |
|
2099
Atea Pharmaceuticals
AVIR
$379M
| $86.2K | ﹤0.01% |
25,733
+6,163
| +31% | +$20.5K |
|
2100
Oil States International
OIS
$522M
| $86K | ﹤0.01% |
16,991
+5,392
| +46% | +$26.9K |
|
Similar funds
ProShare Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.
- ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
- ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
- ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
- ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
- ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
- ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
- ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.
Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.